» Articles » PMID: 36609495

Dietary Vitamin E Intake and New-onset Hypertension

Overview
Journal Hypertens Res
Date 2023 Jan 7
PMID 36609495
Authors
Affiliations
Soon will be listed here.
Abstract

The association between dietary vitamin E intake and the risk of new-onset hypertension remains unknown. We aimed to evaluate the prospective relationship of dietary vitamin E intake with new-onset hypertension in the general Chinese population. A total of 12,177 adults without hypertension at baseline were enrolled from the China Health and Nutrition Survey. Dietary intake was measured by 3 consecutive 24 h dietary recalls at the individual level in combination with a weighing inventory taken over the same 3 days at the household level. The study outcome was new-onset hypertension, defined as a systolic blood pressure ≥140 mmHg and/or a diastolic blood pressure ≥90 mmHg, a diagnosis by a physician, or the use of antihypertensive treatment during follow-up. During a median follow-up duration of 6.1 years, 4269 participants developed new-onset hypertension. Overall, the association between dietary vitamin E intake and new-onset hypertension followed a reverse J-shaped curve (P for nonlinearity <0.001). Accordingly, when dietary vitamin E intake was assessed by quintiles, significantly higher risks of new-onset hypertension were found among participants in the first quintile (<18.75 mg/d: adjusted HR, 1.40; 95% CI, 1.29-1.52) and the fifth quintile (≥40.53 mg/d: adjusted HR, 1.18; 95% CI, 1.09-1.29) compared with those in the second-fourth quintiles (18.75 to <40.53 mg/d). Further adjustments for vitamin A, riboflavin, niacin, vitamin C, zinc, copper, and selenium intake or the intake of vegetables, fruits, legumes, grains, nuts, and vegetable oils did not substantially change the results. In conclusion, there was a reverse J-shaped association between dietary vitamin E intake and new-onset hypertension in general Chinese adults.

Citing Articles

Associations of composite dietary antioxidant index with premature death and all-cause mortality: a cohort study.

Zhong H, Shao Y, Chen X, Wang N, Zhan Y, Gong B BMC Public Health. 2025; 25(1):796.

PMID: 40016675 PMC: 11866784. DOI: 10.1186/s12889-025-21748-x.


Nutrition and Hypertension Researches in 2023: focus on salt intake and blood pressure.

Matsumoto C Hypertens Res. 2025; .

PMID: 39871003 DOI: 10.1038/s41440-024-02089-5.


Joint and independent associations of dietary antioxidant intakes with all-cause and cardiovascular mortality among patients with hypertension: a population-based cohort study.

Zhao S, Cao Y, Liu H, Liu A Nutr J. 2025; 24(1):14.

PMID: 39856716 PMC: 11761209. DOI: 10.1186/s12937-024-01062-9.


Dietary antioxidant index and hypertension in the Iranian population: a nested case-control study within the Fasa adults cohort study.

Firooznia M, Rahimlou M, Sekhavati E, Motazedian M, Tabrizi R Front Nutr. 2024; 11:1476122.

PMID: 39713776 PMC: 11659007. DOI: 10.3389/fnut.2024.1476122.


Association of dietary and circulating antioxidant vitamins with metabolic syndrome: an observational and Mendelian randomization study.

Sun Q, Fan Z, Yao F, Zhao X, Jiang M, Yang M Front Endocrinol (Lausanne). 2024; 15:1446719.

PMID: 39469581 PMC: 11513263. DOI: 10.3389/fendo.2024.1446719.


References
1.
Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P . Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2019; 395(10226):795-808. PMC: 8006904. DOI: 10.1016/S0140-6736(19)32008-2. View

2.
Mills K, Stefanescu A, He J . The global epidemiology of hypertension. Nat Rev Nephrol. 2020; 16(4):223-237. PMC: 7998524. DOI: 10.1038/s41581-019-0244-2. View

3.
Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z . Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015. Circulation. 2018; 137(22):2344-2356. DOI: 10.1161/CIRCULATIONAHA.117.032380. View

4.
Lewington S, Lacey B, Clarke R, Guo Y, Kong X, Yang L . The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. JAMA Intern Med. 2016; 176(4):524-32. DOI: 10.1001/jamainternmed.2016.0190. View

5.
Chiu H, Venkatakrishnan K, Golovinskaia O, Wang C . Impact of Micronutrients on Hypertension: Evidence from Clinical Trials with a Special Focus on Meta-Analysis. Nutrients. 2021; 13(2). PMC: 7916651. DOI: 10.3390/nu13020588. View